Goldman Sachs: Rite Aid Shares Poised For Further Upside

By: via Benzinga
Robert Jones, analyst at Goldman Sachs believes that the Drug Chain stores remain an attractive investment, but Rite-Aid (NYSE: RAD) is ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.